Skip to main navigation Skip to search Skip to main content

Attention-deficit/hyperactivity disorder and substance abuse

  • Elizabeth Harstad
  • , Sharon Levy
  • , Seth D. Ammerman
  • , Pamela K. Gonzalez
  • , Sheryl A. Ryan
  • , Lorena M. Siqueira
  • , Vincent C. Smith
  • , Vivian B. Faden
  • , Gregory Tau
  • , Renee Jarrett
  • , James Baumberger
  • , Katie Crumley

Research output: Contribution to journalArticlepeer-review

Abstract

Attention-deficit/hyperactivity disorder (ADHD) and substance use disorders are inextricably intertwined. Children with ADHD are more likely than peers to develop substance use disorders. Treatment with stimulants may reduce the risk of substance use disorders, but stimulants are a class of medication with significant abuse and diversion potential. The objectives of this clinical report were to present practical strategies for reducing the risk of substance use disorders in patients with ADHD and suggestions for safe stimulant prescribing.

Original languageEnglish (US)
Pages (from-to)e293-e301
JournalPediatrics
Volume134
Issue number1
DOIs
StatePublished - Jul 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health

Fingerprint

Dive into the research topics of 'Attention-deficit/hyperactivity disorder and substance abuse'. Together they form a unique fingerprint.

Cite this